1. Home
  2. SNCR vs BNTC Comparison

SNCR vs BNTC Comparison

Compare SNCR & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • BNTC
  • Stock Information
  • Founded
  • SNCR 2000
  • BNTC 1995
  • Country
  • SNCR United States
  • BNTC United States
  • Employees
  • SNCR N/A
  • BNTC N/A
  • Industry
  • SNCR EDP Services
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • BNTC Health Care
  • Exchange
  • SNCR Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • SNCR 137.5M
  • BNTC 88.1M
  • IPO Year
  • SNCR 2006
  • BNTC N/A
  • Fundamental
  • Price
  • SNCR $11.25
  • BNTC $10.65
  • Analyst Decision
  • SNCR
  • BNTC Strong Buy
  • Analyst Count
  • SNCR 0
  • BNTC 5
  • Target Price
  • SNCR N/A
  • BNTC $22.60
  • AVG Volume (30 Days)
  • SNCR 81.2K
  • BNTC 39.8K
  • Earning Date
  • SNCR 11-12-2024
  • BNTC 11-11-2024
  • Dividend Yield
  • SNCR N/A
  • BNTC N/A
  • EPS Growth
  • SNCR N/A
  • BNTC N/A
  • EPS
  • SNCR N/A
  • BNTC N/A
  • Revenue
  • SNCR $167,615,000.00
  • BNTC N/A
  • Revenue This Year
  • SNCR $7.76
  • BNTC N/A
  • Revenue Next Year
  • SNCR $5.83
  • BNTC N/A
  • P/E Ratio
  • SNCR N/A
  • BNTC N/A
  • Revenue Growth
  • SNCR 33.39
  • BNTC N/A
  • 52 Week Low
  • SNCR $2.70
  • BNTC $2.69
  • 52 Week High
  • SNCR $15.46
  • BNTC $12.89
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 43.11
  • BNTC 55.32
  • Support Level
  • SNCR $10.45
  • BNTC $10.70
  • Resistance Level
  • SNCR $11.44
  • BNTC $11.05
  • Average True Range (ATR)
  • SNCR 0.57
  • BNTC 0.74
  • MACD
  • SNCR -0.06
  • BNTC -0.02
  • Stochastic Oscillator
  • SNCR 31.58
  • BNTC 50.94

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Share on Social Networks: